Patent details
EP3129064 Title: TARGETED THERAPEUTICS
Basic Information
- Publication number:
- EP3129064
- PCT Application Number:
- US2015018442
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP157587171
- PCT Publication Number:
- WO2015134464
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TARGETED THERAPEUTICS
- French Title of Invention:
- THÉRAPIES CIBLÉES
- German Title of Invention:
- ZIELGERICHTETE THERAPEUTIKA
- SPC Number:
Dates
- Filing date:
- 03/03/2015
- Grant date:
- 01/01/2020
- EP Publication Date:
- 15/02/2017
- PCT Publication Date:
- 11/09/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/01/2020
- EP B1 Publication Date:
- 01/01/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 03/03/2020
- Expiration date:
- 03/03/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/12/2019
- Name:
- Madrigal Pharmaceuticals, Inc.
- Address:
- Four Tower Bridge 200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania 19428, United States (US)
Inventor
1
- Name:
- YING, Weiwen
- Address:
- United States (US)
2
- Name:
- CHIMMANAMADA, Dinesh, U.
- Address:
- United States (US)
Priority
- Priority Number:
- 201461947108 P
- Priority Date:
- 03/03/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 47/50;
Publication
European Patent Bulletin
- Issue number:
- 202001
- Publication date:
- 01/01/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|